NCT00493883View on ClinicalTrials.gov

Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Carcinoma, HepatocellularLiver Neoplasms
Interventions
DEVICE

yttrium Y 90 microspheres (TheraSphere®)

Y-90 is incorporated into very tiny glass beads, it can be injected into the liver through the blood vessels supplying the liver

Trial Locations (1)

74133

Cancer Treatment Centers of America at Southwestern Regional Medical Center, Tulsa

All Listed Sponsors
lead

Southwestern Regional Medical Center

OTHER

NCT00493883 - Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors | Biotech Hunter | Biotech Hunter